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CASE REPORT
Bartonella henselae AS A PUTATIVE CAUSE OF CONGENITAL CHOLESTASIS
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SUMMARY
Severe anemia and cholestatic hepatitis are associated with bartonella infections. A putative vertical Bartonella henselae infection 
was defined on the basis of ultrastructural and molecular analyses in a three-year-old child with anemia, jaundice and hepatosplenomegaly 
since birth. Physicians should consider bartonellosis in patients with anemia and hepatitis of unknown origin. 
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INTRODUCTION
Bartonella spp. are emerging bacterial pathogens. The clinical 
spectrum of human bartonelloses has increased rapidly and several species 
of this genus have already been associated with human infections1,2. Cats 
comprise the most well-known and studied reservoirs. Abortion related to 
infection by Bartonella henselae has already been described in equines3. 
Bilavsky et al. (2012) related a case of one woman who presented with 
clinical cat scratch disease during the first month of pregnancy and had 
a spontaneous abortion4. Although vertical transmission in felines has 
not been documented, previously infected females have greater difficulty 
in becoming pregnant and maintaining their pregnancies5. Conversely, 
vertical transmission has been documented in mice experimentally 
infected with Bartonella birtlesii6. Breitschwerdt et al. (2010) showed 
molecular evidence of perinatal transmission of Bartonella vinsonii 
subsp. berkhoffii and B. henselae to a child7.
In a case-controlled study performed in HIV positive patients Mohle-
Boetani et al. (1996) observed that anemia and elevated serum alkaline 
phosphatase were associated with B. henselae and Bartonella quintana 
infections8. Angiomatous proliferation and granulomatous reactions, 
severe anemia and cholestatic hepatitis are examples of the wide spectrum 
of clinical manifestations associated with Bartonella sp. infections9. 
CASE REPORT
We report a case of a three-year-old child born to an asymptomatic 
woman and presenting with anemia, jaundice and hepatosplenomegaly 
since birth, whose putative vertically transmitted infection by 
B. henselae was defined on the basis of ultrastructural microscopy 
findings in liver biopsy, and the molecular detection of B. henselae 
DNA directly from the mother’s blood sample and also from the child’s 
blood culture bottles that had yielded negative blood culture results. 
A full term white female neonate was delivered by C-section due to 
functional dystocia after a prenatal care without intercurrences. The 
birth weight was 3,400 g and the Apgar scores were 8 and 10 in the 
first and fifth minutes, respectively. The mother was asymptomatic and 
had no morbid antecedents, although she reported domiciliary contact 
with cats prior to and throughout pregnancy. 
At eight days of life she began to present with choluria and acholic 
stools. The abdominal ultrasound examination revealed absence of bile 
duct dilation and the presence of gallbladder hypocontractility. The child 
had remained hospitalized in the maternity ward where she was born until 
she was referred to the University of Campinas, Sao Paulo, Brazil, on the 
tenth day of life. At admission, the neonate presented with a urinary tract 
infection caused by Enterobacter cloacae which was successfully treated 
for 10 days with amikacin. At this time the hypothesis of trans-infectious 
hepatitis and cholestasis was considered. Acute infectious diseases were 
investigated and serology to search for anti-IgM antibodies were negative 
for cytomegalovirus (CMV), syphilis, HBV, HCV, and toxoplasmosis, 
with positive and low anti-IgG detection only for toxoplasmosis and 
CMV. A first percutaneous liver biopsy performed at 12 days of age 
evidenced a lobular neonatal cholestatic syndrome and the presence of 
a bile channel plug. Ursodeoxycholic acid was prescribed. 
As the jaundice worsened and the liver enlarged at 30 days old the 
patient was submitted to a cholangiography that discarded the presence 
of bile-duct atresia. However, a second liver biopsy performed at this 
time indicated the presence of a lobular neonatal cholestatic syndrome, 
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some giant cells and ductopenia. A battery of tests was performed to 
exclude the most common inborn metabolic errors. A Na/Cl sweat test, 
an ophthalmologic exam, X-rays of the cranium, spine and chest were 
normal. The child evolved with clinical deterioration, increment of the 
anemia, jaundice, hepatosplenomegaly and choluria. The patient also 
developed thrombocytopenia, a leukemoid reaction, hypoalbuminemia 
and ascites. A myelogram was performed and showed an erythroid 
hyperplasia. Other laboratory parameters showed an indirect bilirubin 
of 15mg/dL and a direct bilirubin of 41.8 mg/dL. Tyrosinaemia was 
also excluded. 
At two months old the infant underwent a third liver biopsy that 
corroborated the previous findings. Moreover, an accentuated giant cell 
transformation was observed and an extra hepatic cholestasis could 
not be discarded due to the lack of portal spaces. Therefore, at 77 days 
of age, due to three inconclusive liver percutaneous biopsies and the 
aggravation of the jaundice, a surgical liver biopsy was indicated to 
definitively confirm or exclude the diagnosis of a bile duct atresia (Fig. 1). 
The histological examination upheld the accentuated transformation of 
giant cells and the absence of any morphological hallmark morphological 
indicators of bile-duct atresia. The Transmission Electron Microscopy 
(TEM) did not show any evidence of metabolic diseases. 
In addition to the negative CMV serology (positive low IgG titers 
and negative IgM), a DNA-PCR-CMV was performed in the liver tissue 
and also resulted negative. Even so, as CMV is a frequent infectious 
agent associated with the neonatal cholestatic syndrome, the child had 
no confirmed diagnosis at that time and her clinical conditions were 
deteriorating, so that, a 21 days of treatment with ganciclovir was initiated 
at the third month of life, but resulted in no improvement of the clinical 
and laboratory parameters. 
Therefore, the etiologic investigation proceeded. The anti-smooth 
muscle antibody test was positive (1:80), but the direct anti-human 
globulin test (Coombs) showed a negative result. The factor V (Leiden) 
level was 100%. Parvovirus infection was investigated by means of a 
DNA-PCR performed in a peripheral blood sample from the child and 
resulted negative. 
A bone marrow biopsy was performed and showed a normocellular 
marrow for the patient’s age, a moderate reduction in the granulocyte/
erythrocyte ratio and a discrete delay of the erythroid series maturation. 
A fifth liver biopsy was carried at three months old and it 
did not bring any new evidence. At that time, the diagnostic 
hypothesis was an autoimmune hepatitis, so the child was prescribed 
2 mg/kg/day of prednisone and 1.5 mg/kg/day of azathioprine, and her 
serum had transaminases returned to normal levels, although the anemia 
had persisted. 
Further investigation of hemolytic diseases was undertaken when 
she was four months old and showed a positive direct anti-globulin 
test with IgG and C3d, nevertheless the acid elution was negative. 
Biphasic hemolysin research also presented weak positive results. All 
the tests were repeated after four weeks and the results were negative. 
The paroxysmal nocturnal hemoglobinuria was also discarded due to a 
normal flow cytometry. 
As a consequence of the persistent anemia, the first transfusion of 
Red Blood Cells (RBC) was performed when she was six months old 
(hemoglobin was 6.7 mg/dL) and from this period, RBC transfusions 
had to be performed every three or four weeks. 
Medical intercurrences during the first and the second years of life 
included the persistence of anemia and one episode of urinary tract 
infection caused by Klebsiella sp. which was successfully treated. A 
posterior ultrasound investigation of the kidneys and the urinary tract 
was normal as well as the voiding urethrocystography. Even though, 
the girl has received cephalosporin to prevent urinary tract infections. 
At the age of three years, the patient still required nearly monthly 
RBC transfusions (without iron chelation) and continued to receive 
prednisone and azathioprine to control the hepatic auto-immune process. 
In order to continue the anemia investigation, a drop of child’s blood was 
fixed in Karnovsky solution, then processed as previously described10 
and examined by TEM. Structures inside erythrocytes with size and 
morphology compatible with Gram-negative bacteria were observed. The 
TEM of a deparaffined liver fragment from the first biopsy performed at 
12 days of age has also evidenced the presence of a similar etiological 
agent within erythrocytes (Fig. 2). 
At this time, the patient’s mother decided to donate blood at the 
UNICAMP Blood Bank (HEMOCENTRO). As Bartonella sp. infection 
had been suggested to explain the persistent anemia, a TEM was 
performed in a drop of this donated blood showing the presence of rare 
RBC containing structures suggestive of Gram-negative bacteria11.
In addition, one peripheral blood sample from the child was negative 
by a previously described one-round species-specific amplification 
targeting to the B. henselae FtsZ gene12. 
Due to the mother and the child TEM findings supporting the 
diagnosis of bartonellosis, the girl was treated with oral erythromycin 
for 14 days evolving with a mild improvement of the anemia. 
She was readmitted 30 days later and a fifth new liver biopsy was 
performed and still showed the presence of giant cells. At this time, by 
the systemic and severe involvement she began an intravenous antibiotic 
Fig. 1 - Marked transformation gigantocellular of hepatocytes (HE-400x)
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therapy with gentamicin (7mg/kg/day) for 14 days and erythromycin 
(50mg/kg/day) for 28 days. After two weeks, there was a partial regression 
of the hepatosplenomegaly with subsequent reduction of the abdominal 
volume and after the 28 days of intravenous antibiotic treatment with 
gentamicin and erythromycin, there was a transitory reduction of the 
patient’s need for transfusion and we could discontinue the prednisone 
and azathioprine without new increments of the hepatic enzymes. The 
hemoglobin at admission was 8 g/dL and, at the end of the hospital 
stay, 6g/dL so that the patient was once again transfused before she 
was discharged with a two month prescription of oral azithromycin. 
Afterwards, she returned to the oral erythromycin regimen until the 
completion of splenectomy eight month later. After that, the patient did 
not require further blood transfusions. The liver fragments collected 
during the splenectomy showed chronic liver disease with portal 
enlargement and portal-portal septa, haemosiderosis as well as severe 
myeloid metaplasia. No giant cells were observed. 
In an attempt to confirm the TEM findings, considering that all the 
blood cultures of the child were negative, including those performed in 
special culture media to isolate Bartonella spp., a nested-FtsZ-PCR was 
standardized and used to test eleven stored blood samples of the child 
collected before the prescription of antibiotics to treat the bartonellosis 
at three years of age. The outer primers being the same that had already 
been described12 and were coupled to a second amplification with newly 
designed inner primers13: forward-CAAAACGGTTGGAGAGCAGT and 
reverse-CGCCTGTCATCTCATCAAGA. Aside from the child’s eleven 
blood samples, one aliquot of the mother’s blood from the donated blood 
bag was also tested11. Unfortunately, neither the fragments of the liver 
biopsies nor the placenta were available for amplification. Only the 
mother’s blood from the donated bag was positive by the nested-FtsZ 
PCR for B. henselae. However, eleven peripheral blood samples from 
the child that had been diluted in BACTEC bottles to perform the blood 
cultures and stored after the final negative blood culture result were 
also tested. Some of them were collected when the patient was under 
antibiotic treatment. Three of these eleven samples were positive by the 
species-specific B. henselae nested-FtsZ PCR. The amplification products 
were submitted to enzyme restriction with HpyCH4IV (New England 
Biolabs, Ipswich, USA) to confirm the specificity of amplifications, 
generating two fragments of 127 and 91 bp, as expected for B. henselae. 
The entire amplification products were also submitted to an automated 
DNA sequencing (ABI 3100, Applied Biosystems, USA) and showed 
that the FtsZ DNA fragments of the mother and her daughter were 100% 
homologous with the Houston 1 strain (GenBank accession number 
BX897699).
The child is currently 12 years old and is under benzathine penicillin 
treatment schedule every 21 days due to the splenectomy. She has been 
monitored ever since without other infectious episodes. 
DISCUSSION
Several diagnostic hypotheses were made as this patient’s case 
evolved. Initially a transinfectious cholestasis due to a urinary tract 
infection was considered14. However, the patient cholestasis did not 
improve after the successful treatment. The histological examination 
revealed morphological alterations suggestive of neonatal hepatitis. 
Since discrete ductopenia was considered in the first biopsy, the concern 
was to discard the association with an infectious agent, or alternatively 
with genetic conditions such as the Alagille syndrome or the alpha-1 
antitrypsin deficiency15. The specific investigation of these syndromes 
turned up negative and ductopenia was not confirmed. 
As the case evolved, clinical features worsened with jaundice 
becoming accentuated. At this point, the hypothesis that needed to be 
discarded was a hepatitis induced bile-duct atresia. The intra-operatory 
cholangiography and surgical liver biopsy, once again, discarded this 
hypothesis. 
Following this, the persistence of the anemia and the liver biopsies 
showing an accentuated number of giant cells lead to a new diagnostic 
hypothesis of hepatitis associated with an immune hemolytic anemia. It is 
known that the presence of giant cells is characteristic of several hepatic 
injuries taking place during the prenatal period, caused by CMV, rubella, 
herpes simplex, treponema, paramyxoviruses, autoimmune diseases, 
metabolic diseases and drugs. 
The presence of a hemolytic anemia associated with giant cells in 
the liver identifies a pathologic condition first described by Bernard et 
al. (1981)16 who reported four cases, three of which with fatal outcome. 
In the currently described patient her clinical/laboratory parameters 
were compatible with this diagnosis, excepting for the negative direct 
anti-human globulin test (Coombs)16-18. 
The patient began the treatment with immunosuppressive drugs 
and the exams revealed a decrease in liver transaminases, however the 
anemia persisted. This behavior has been previously observed in a case 
reported by Gorelik et al. (2004) in which a good therapeutic response 
was obtained with the administration of anti-CD20 antibodies19. In the 
present patient, the anti-CD20 was not used because the etiology was 
not formally defined. 
Neonatal hepatitis with presence of giant cells could have been 
caused by an infectious agent transmitted during pregnancy. The positive 
biphasic hemolysin exam performed prior to the corticotherapy also 
reinforces this possibility. However, in the last liver fragment obtained 
during splenectomy after a prolonged antibiotic therapy for B. henselae 
Fig. 2 - Transmission electron micrography of a deparaffined liver fragment from the biopsy 
performed at 12 days of age shows an erythrocyte containing an organism with typical 
trilaminate cell wall structure
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and the after immunosuppressive drugs suspension, no signs of activity 
of hepatitis were found.
Severe anemia is a hallmark of Oroya fever, the febrile phase of 
Carrion’s bartonellosis, caused by B. bacilliformis, and it has also been 
described in infections by B. henselae. This bacterium is also implicated 
in cryptogenic hepatitis, bacillary peliosis hepatitis, granulomatous and 
micro-abscesses in the liver9. 
In the present case report Bartonella sp. infection was suggested 
by TEM, because they are the unique known intraerythrocytic bacteria. 
Later, B. henselae was confirmed by species-specific nested-FtsZ-PCR 
followed by confirmatory tests (enzyme restriction and automated DNA 
sequencing). The fact that the initial one-round FtsZ-PCR was negative 
could be attributed to a low bacteremia and a lack of sensitivity of the 
molecular test. Considering the positive nested-FtsZ-PCR obtained in 
three of eleven child’s blood samples after seeding in culture media, if 
on one hand the patient was receiving prophylactic antibiotic to prevent 
urinary tract infections at the time of blood collection what could have 
reduced the bacterial load, on the other hand, in these three samples, 
albeit the dilution of the child’s blood in culture media, the incubation 
of the blood samples in the culture bottles have probably favored the 
bacteria replication, therefore increasing the bacterial load. Moreover, 
one should expect a nested amplification to be more sensitive than a 
one-round PCR. 
Another possibility that is worth to be mentioned is the acquisition 
of infection by blood transfusion from an asymptomatic donor. This 
hypothesis, although plausible, does not justify the child’s anemia, 
jaundice and hepatosplenomegaly already present at birth. After the 
TEM detection of Bartonella sp. within erythrocytes in the blood bag 
donated by the mother, the Blood Bank discarded this bag, but as the 
mother was asymptomatic, it is likely that other blood donors could have 
asymptomatic infections caused by Bartonella spp. that are inadvertently 
transmitted to blood receivers. 
Vertical transmission became more likely when the asymptomatic 
mother’s blood revealed the presence of bacillary structures within rare 
RBC of the child’s first liver biopsy performed on the 12th day of life, 
five months before the first blood transfusion had taken place. 
Another point that merits discussion is the possibility of a domiciliary 
acquisition of infection by the child from infected cats. Once again, the 
TEM findings in the liver biopsy performed on the 12th day of life states 
against this hypothesis because the child had been hospitalized since 
birth until the fifth month of life. 
The diagnosis of the mother’s asymptomatic infection by B. henselae 
made by TEM and the nested-FtsZ-PCR, and the 100% of homology 
between the sequences obtained from the patient and her mother and the 
Houston-1 strain also reinforces the occurrence of a vertical transmission 
in the present case. 
The existence of asymptomatic human hosts of Bartonella spp. was 
known, but the case presented herewith is relevant because it opens up 
the possibilities of other etiological agents to be associated with vertical 
transmission and potentially leading to intrahepatic neonatal cholestasis 
and hepatitis.
This case exemplifies a chronic inflammatory infectious process1. 
Although the bacteria were visible in a liver fragment of the biopsy 
performed at 12 days of age, the use of high doses of immunosuppressant 
agents was able to normalize liver enzyme levels though the persistence 
of anemia. 
Bartonelllosis may be more frequent than previously thought. To date, 
we do not have a gold standard test to confirm Bartonella sp. infections 
in clinical practice, but the lack of considering the diagnostic hypothesis 
of infection by these bacteria still stands as the major limiting factor 
towards diagnosing new cases of this infection. 
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